Matt Britz
Amministratore Delegato presso Affyimmune Therapeutics, Inc.
Posizioni attive di Matt Britz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Amministratore Delegato | 19/03/2024 | - |
| Direttore operativo | 01/01/2022 | - | |
| Corporate Officer/Principal | 01/06/2021 | 01/01/2022 | |
| Presidente | 01/06/2021 | 19/03/2024 |
Storia della carriera di Matt Britz
Formazione di Matt Britz
| Washington University in St. Louis | Graduate Degree |
| University of Massachusetts | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Borsa valori
- Insiders
- Matt Britz
- Esperienza
